The Cut-Off Value of Serum Anti-Müllerian Hormone Levels for the Diagnosis of Turner Syndrome with Spontaneous Puberty

Overview

Journal Int J Endocrinol

Publisher Wiley

Specialty Endocrinology

Date 2023 Feb 27

PMID 36844105

Authors

Jin Wang

Tian Lan

Xiang Dai

Luhong Yang

Xijiang Hu

Hui Yao

Affiliations

Soon will be listed here.

Abstract

Objective: Preservation of fertility in Turner syndrome (TS) patients may be feasible through cryopreservation of ovarian tissue before follicles begin to disappear. Anti-Müllerian hormone (AMH) is said to be a predictive factor of spontaneous pubertal development in TS. We aimed to determine the cut-off values of AMH for the diagnosis of TS girls with spontaneous puberty. : A total of 95 TS patients between 4 and 17 years were evaluated at the Department of Pediatric Genetic Metabolism and Endocrinology from July 2017 to March 2022. Serum AMH, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) levels were analyzed according to age, karyotype, pubertal development, and ultrasound ovarian visualization. Receiver-operating characteristic (ROC) curve analyzes were used to test the utility of AMH for the diagnosis of TS girls with spontaneous puberty.

Results: One-fourth of TS girls aged 8-17 years had spontaneous breast development, with the ratios as follows: 45, X (6/28, 21.4%), mosaicism (7/12, 58.3%), and mosaicism with structural X chromosome abnormalities (SCA) (2/13, 15.4%), SCA (1/13, 7.7%), and Y chromosome (1/3, 33.3%). The AMH cut-off value for the prediction of spontaneous puberty in TS patients was 0.07 ng/ml, with sensitivity and specificity both at 88%. FSH, LH levels, and Karyotypes could not be considered as markers of spontaneous puberty in TS ( > 0.05). A strong relationship was observed between serum AMH levels and spontaneous puberty or ultrasound bilateral ovarian visualization.

Conclusions: The AMH cut-off value for the prediction of spontaneous puberty in TS girls aged 8-17 years was 0.07 ng/ml, with sensitivity and specificity both at 88%. However, spontaneous puberty in these patients is not predictable based on karyotype or FSH or LH levels.

Citing Articles

Live birth rate after oocyte donation in females diagnosed with turner syndrome: a systematic review and meta-analysis.

Rashidian P, Parsaei M, Karami S, Sharifi T, Sadin Z, Salehi S BMC Pregnancy Childbirth. 2024; 24(1):605.

PMID: 39294592 PMC: 11411911. DOI: 10.1186/s12884-024-06801-8.

Navigating fertility dilemmas across the lifespan in girls with Turner syndrome-a scoping review.

van der Coelen S, van der Velden J, Nadesapillai S, Braat D, Peek R, Fleischer K Hum Reprod Update. 2024; 30(4):383-409.

PMID: 38452347 PMC: 11215162. DOI: 10.1093/humupd/dmae005.

References

Moolhuijsen L, Visser J . Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020; 105(11). PMC: 7486884. DOI: 10.1210/clinem/dgaa513. View

Yates A, Jopling H, Burgoyne N, Hayden K, Chaloner C, Tetlow L . Paediatric reference intervals for plasma anti-Müllerian hormone: comparison of data from the Roche Elecsys assay and the Beckman Coulter Access assay using the same cohort of samples. Ann Clin Biochem. 2019; 56(5):536-547. PMC: 6688133. DOI: 10.1177/0004563219830733. View

Soderstrom-Anttila V, Pinborg A, Karnis M, Reindollar R, Paulson R . Should women with Turner syndrome be allowed to carry their own pregnancies?. Fertil Steril. 2019; 112(2):220-225. DOI: 10.1016/j.fertnstert.2019.06.003. View

Ruszala A, Wojcik M, Starzyk J . Evaluation of the usefulness of antymüllerian hormone and inhibin B as markers of ovarian activity in patients with Turner syndrome - preliminary results. Pediatr Endocrinol Diabetes Metab. 2020; 26(2):84-88. DOI: 10.5114/pedm.2020.95622. View

Kruszka P, Addissie Y, Tekendo-Ngongang C, Jones K, Savage S, Gupta N . Turner syndrome in diverse populations. Am J Med Genet A. 2019; 182(2):303-313. PMC: 8141514. DOI: 10.1002/ajmg.a.61461. View

Tehrani F, Mansournia M, Solaymani-Dodaran M, Azizi F . Age-specific serum anti-Müllerian hormone levels: estimates from a large population-based sample. Climacteric. 2014; 17(5):591-7. DOI: 10.3109/13697137.2014.912262. View

Coelho Neto M, Ludwin A, Borrell A, Benacerraf B, Dewailly D, da Silva Costa F . Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound Obstet Gynecol. 2017; 51(1):10-20. DOI: 10.1002/uog.18945. View

Hamza R, Mira M, Hamed A, Ezzat T, Sallam M . Anti-Müllerian hormone levels in patients with turner syndrome: Relation to karyotype, spontaneous puberty, and replacement therapy. Am J Med Genet A. 2018; 176(9):1929-1934. DOI: 10.1002/ajmg.a.40473. View

Visser J, Hokken-Koelega A, Zandwijken G, Limacher A, Ranke M, Fluck C . Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Hum Reprod. 2013; 28(7):1899-907. DOI: 10.1093/humrep/det089. View

10.

Mavridi A, Ntali G, Theodora M, Stamatelopoulos K, Michala L . A Spontaneous Pregnancy in a Patient with Turner Syndrome with 45,X/47,XXX Mosaicism: A Case Report and Review of the Literature. J Pediatr Adolesc Gynecol. 2018; 31(6):651-654. DOI: 10.1016/j.jpag.2018.07.005. View

11.

Purushothaman R, Lazareva O, Oktay K, Ten S . Markers of ovarian reserve in young girls with Turner's syndrome. Fertil Steril. 2010; 94(4):1557-1559. DOI: 10.1016/j.fertnstert.2009.12.026. View

12.

Prentice P . Fifteen-minute consultation: Clinical pubertal assessment. Arch Dis Child Educ Pract Ed. 2021; 107(4):253-256. DOI: 10.1136/archdischild-2020-320386. View

13.

Gravholt C, Viuff M, Brun S, Stochholm K, Andersen N . Turner syndrome: mechanisms and management. Nat Rev Endocrinol. 2019; 15(10):601-614. DOI: 10.1038/s41574-019-0224-4. View

14.

Donaldson M, Gault E . Promoting healthy behaviour in Turner syndrome-the challenge begins in childhood. Acta Paediatr. 2021; 110(8):2298-2300. DOI: 10.1111/apa.15906. View

15.

Noordman I, van der Velden J, Timmers H, Pienkowski C, Kohler B, Kempers M . Karyotype - Phenotype Associations in Patients with Turner Syndrome. Pediatr Endocrinol Rev. 2019; 16(4):431-440. DOI: 10.17458/per.vol16.2019.nvt.karyotypeturnersyndrome. View

16.

Steiner A . AMH as a Predictor of the Final Menstrual Period. J Clin Endocrinol Metab. 2020; 105(4). DOI: 10.1210/clinem/dgaa025. View

17.

Wang J, Yao T, Zhang X, Chen Q, Gong S, Jiang L . Age-specific reference intervals of serum anti-Müllerian hormone in Chinese girls. Ann Clin Biochem. 2021; 58(4):350-357. DOI: 10.1177/00045632211002879. View

18.

Calanchini M, Aye C, Orchard E, Baker K, Child T, Fabbri A . Fertility issues and pregnancy outcomes in Turner syndrome. Fertil Steril. 2020; 114(1):144-154. DOI: 10.1016/j.fertnstert.2020.03.002. View

19.

Pankhurst M . A putative role for anti-Müllerian hormone (AMH) in optimising ovarian reserve expenditure. J Endocrinol. 2017; 233(1):R1-R13. DOI: 10.1530/JOE-16-0522. View

20.

Kallio S, Aittomaki K, Piltonen T, Veijola R, Liakka A, Vaskivuo T . Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries. Hum Reprod. 2012; 27(3):854-60. DOI: 10.1093/humrep/der473. View